Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol infusion for refractory chronic primary insomnia
NCT02043977Phase 1Completed
- Start
- Jun 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of propofol in Chronic Primary Insomnia. Primary endpoints: Leeds Sleep Evaluation Questionnaire at 180 days and Polysomnography at 90 days. Started Jun 2013; status: completed.
02
Drugs
propofol
03
Conditions
Chronic Primary Insomnia
Beyond the preview
Go deeper on NCT02043977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02043977.